Table of Content 1. Research Methodology 2. Executive Summary 3. Strategic Recommendations 4. Antidepressant Drugs Market Outlook 5. Global Antidepressant Drugs Market: Growth and Forecast 5.1. By Value (2013-2017) 5.2. By Value (2013-2017) 6. Global Antidepressant Drugs Market: By Drugs Class 6.1. Global Antidepressant Drugs Market-By Drugs Class: Breakdown (%) 6.1.1. Global Antidepressant Drugs Market Size and Share, By Drugs, 2017 6.1.2. Global Antidepressant Drugs Market Size and Share, By Drugs, 2023 6.2. Global Selective Serotonin Reuptake Inhibitors Market Overview 6.2.1. By Value (2013-2023) 6.3. Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview 6.3.1. By Value (2013-2023) 6.4. Global Monoamine Oxidase Inhibitors Market Overview 6.4.1. By Value (2013-2023) 6.5. Global Tricyclic Antidepressant Drugs Market Overview 6.5.1. By Value (2013-2023) 6.6. Global Benzodiazepines Antidepressant Drugs Market Overview 6.6.1. By Value (2013-2023) 6.7. Global Antipsychotics Antidepressant Drugs Market Overview 6.7.1. By Value (2013-2023) 6.8. Global Novel Agents Antidepressant Drugs Market Overview 6.8.1. By Value (2013-2023) 6.9. Global Other Antidepressant Drugs Market Overview 6.9.1. By Value (2013-2023) 7. Global Antidepressant Drugs Market: By Sales Channels 7.1. Global Antidepressant Drugs Market-By Sales Channels: Breakdown (%) 7.1.1. Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017 7.1.2. Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023 7.2.Global Antidepressant Drugs Market, By Hospital & Clinics Overview 7.2.1. By Value (2013-2023) 7.3. Global Antidepressant Drugs Market, By Retail Pharmacies Overview 7.3.1. By Value (2013-2023) 7.4. Global Antidepressant Drugs Market, By Others Overview 7.4.1. By Value (2013-2023) 8. Global Antidepressant Drugs Market: Pipeline Analysis 9. Global Antidepressant Drugs Market: Regional Analysis 9.1. Global Antidepressant Drugs Market, By Region: Breakdown (%) 9.1.1. Global Antidepressant Drugs Market Size, By Region, 2017 (%) 9.1.2. Global Antidepressant Drugs Market Size, By Region, 2023 (%) 9.2. Global Antidepressant Drugs Market Size, By Region, 2023 (%) 9.2.1. By Value (2013-2017) 9.2.2. By Value (2018-2023) 9.3. North America Antidepressant Drugs Market: Segment Analysis 9.3.1. North America Antidepressant Drugs Market: By Drug Class 9.3.1.1.North America Antidepressant Drugs Market Size, By Value, 2013-2023 9.3.2. North America Antidepressant Drugs Market: By Sales Channels 9.3.2.1. North America Antidepressant Drugs Market Size, By Value, 2013-2023F 9.4. North America Antidepressant Drugs Market: Country Analysis (U.S. and Canada) 9.4.1. U.S. Antidepressant Drugs Market, By Value (2013-2023) 9.4.1.1. U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 9.4.2. Canada Antidepressant Drugs Market, By Value (2013-2023) 9.4.2.1. Canada Antidepressant Drugs Market, By Dr

List of Figures Figure 1: Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) Figure 2: Global YLDs of Depressive Disorders (2013-2016, %) Figure 3: Global DALYs of Anxiety Disorders (2013-2016 %) Figure 4: DALYs due to Mental and Substance Abuse (2016) Figure 5: World Female Population, 2012-2016 (Million) Figure 6: World Population 65 Years & Above (% of Total), 2012-2016 Figure 7: Global Unemployment (2016, 2017E, 2018F, (Millions) Figure 8: Global Health Expenditure Per Capita, By Select Countries, (2016, USD) Figure 9: Global Health Expenditure Per Capita, (2012-2016, USD Trillion) Figure 10: Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion) Figure 11: Global Antidepressant Drugs Market Size, By Drugs, 2017 (%) Figure 12: Global Antidepressant Drugs Market Size, By Drugs Class, 2023F (%) Figure 13: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 14: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 15: SSRIs Antidepressants Usage in Different Disorders (%) Figure 16: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 17: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 18: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 19: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 20: Global Tricyclic Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 21: Global Tricyclic Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 22: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 23: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 24: Global Antipsychotics Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 25: Global Antipsychotics Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 26: Global Novel Agents Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 27: Global Novel Agents Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 28: Global Others Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) Figure 29: Global Others Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) Figure 30: Global Antidepressant Drugs Market Size, By Sales Channels, 2017 (%) Figure 31: Global Antidepressant Drugs Market Size, By Sales Channels, 2023 (%) Figure 32: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2013-2017 (USD Billion) Figure 33: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2018E-2023F (USD Billion) Figure 34: Global Antidepressant D